The structural profiles are close, with W. R. Berkley carrying a narrow edge on growth. Jazz Pharmaceuticals still has the edge on growth, which keeps the comparison from looking entirely one-sided. In the market, Jazz Pharmaceuticals carries the stronger setup — intact trend against W. R. Berkley's broken trend. That leaves a split case: the structural lead stays with W. R. Berkley, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
The page question resolves through growth, where Jazz Pharmaceuticals plc holds the stronger read even though the broader score still favours W. R. Berkley Corporation.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The match is driven mainly by investment intensity and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
The setup remains mixed because the stronger profile and the more supportive price setup do not sit on the same side.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where JAZZ and WRB each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The current lead is backed by a stronger multi-year growth trajectory.
On the market side, Jazz Pharmaceuticals carries the stronger trend while W. R. Berkley's trend has broken — the market setup does not confirm the structural advantage.
The lead is built on both growth and profitability — though growth still provides a counterweight.
Break down the JAZZ vs WRB comparison across all dimensions with the full interactive tool.
Explore how JAZZ and WRB each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.